• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Reliability, validity and responsiveness to change of the Patient Report of Extent of Psoriasis Involvement (PREPI) for measuring body surface area affected by psoriasis.用于测量银屑病受累体表面积的患者报告银屑病严重程度(PREPI)的可靠性、有效性和对变化的反应性。
Br J Dermatol. 2010 Apr;162(4):835-42. doi: 10.1111/j.1365-2133.2009.09589.x. Epub 2009 Nov 10.
2
The self-administered psoriasis area and severity index is valid and reliable.自我管理的银屑病面积和严重程度指数是有效且可靠的。
J Invest Dermatol. 1996 Jan;106(1):183-6. doi: 10.1111/1523-1747.ep12329912.
3
Measuring functional disability in early rheumatoid arthritis: the validity, reliability and responsiveness of the Recent-Onset Arthritis Disability (ROAD) index.测量早期类风湿性关节炎的功能残疾:近期发病关节炎残疾(ROAD)指数的有效性、可靠性和反应性。
Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S31-42.
4
Measurement properties of the patient global assessment numerical rating scale in moderate-to-severe psoriasis.中重度银屑病患者整体评估数字评定量表的测量特性。
Br J Dermatol. 2023 Sep 15;189(4):437-446. doi: 10.1093/bjd/ljad188.
5
Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort.医师全球评估与体表面积乘积:纵向队列中银屑病严重程度的简单静态指标。
J Am Acad Dermatol. 2013 Dec;69(6):931-7. doi: 10.1016/j.jaad.2013.07.040. Epub 2013 Sep 17.
6
Validation of an Optical Pencil Method to Estimate the Affected Body Surface Area in Psoriasis.验证一种光学铅笔法来估算银屑病受累体表面积。
Actas Dermosifiliogr (Engl Ed). 2020 Mar;111(2):143-148. doi: 10.1016/j.ad.2019.07.002. Epub 2019 Aug 28.
7
The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment.三种银屑病评估工具的可靠性:银屑病面积和严重程度指数、体表面积和医师整体评估。
Adv Clin Exp Med. 2017 Aug;26(5):851-856. doi: 10.17219/acem/69804.
8
Validation of a simple measure of psoriasis severity based on a longitudinal study of Chinese patients.基于对中国患者的纵向研究验证一种简单的银屑病严重程度衡量方法。
Eur J Dermatol. 2020 Dec 1;30(6):674-679. doi: 10.1684/ejd.2020.3914.
9
Measurement properties of a patient-reported outcome measure assessing psoriasis severity: The psoriasis symptoms and signs diary.一种评估银屑病严重程度的患者报告结局指标的测量属性:银屑病症状与体征日记。
J Dermatolog Treat. 2016 Aug;27(4):322-7. doi: 10.3109/09546634.2015.1114567. Epub 2015 Dec 4.
10
Reliability and Validity of the Psoriasis Symptom Inventory in Patients With Psoriatic Arthritis.银屑病关节炎患者银屑病症状量表的信度和效度
Arthritis Care Res (Hoboken). 2015 Dec;67(12):1750-6. doi: 10.1002/acr.22653.

引用本文的文献

1
The FORWARD Psoriasis Registry: Patient-Reported Outcomes in a Novel Psoriasis Registry and Comparison of Traditional, Dermatologist-Led Enrollment With Web-Based Patient Enrollment.FORWARD银屑病注册研究:新型银屑病注册研究中患者报告的结局以及传统皮肤科医生主导招募与基于网络的患者招募的比较
J Psoriasis Psoriatic Arthritis. 2024 Nov 20:24755303241303089. doi: 10.1177/24755303241303089.
2
Likelihood of COVID-19 Vaccination Among Individuals Living With Psoriatic Disease: Results From a Large Real-World Survey.银屑病患者接种新冠病毒疫苗的可能性:一项大型真实世界调查结果
J Psoriasis Psoriatic Arthritis. 2022 Jan;7(1):17-23. doi: 10.1177/24755303211067822. Epub 2021 Dec 10.
3
Prevalence and Impact of Unacceptable Symptom State among Patients with Psoriatic Arthritis: Results from the National Psoriasis Foundation's 2019 Annual Survey.银屑病关节炎患者中不可接受症状状态的患病率及影响:美国国家银屑病基金会2019年年度调查结果
JID Innov. 2024 Jun 6;4(5):100292. doi: 10.1016/j.xjidi.2024.100292. eCollection 2024 Sep.
4
Association Between Poor Sleep and Myocardial Infarction in Patients with Psoriasis: Findings from a Cross-Sectional Study with the National Psoriasis Foundation.银屑病患者睡眠质量差与心肌梗死之间的关联:一项与国家银屑病基金会合作的横断面研究结果
Dermatol Ther (Heidelb). 2023 Nov;13(11):2903-2909. doi: 10.1007/s13555-023-01045-4. Epub 2023 Oct 5.
5
Ixekizumab Real-World Effectiveness at 24 Weeks in Patients with Psoriasis: Data from the United States Taltz Customer Support Program.司库奇尤单抗治疗银屑病患者24周的真实世界有效性:来自美国Taltz客户支持项目的数据
Dermatol Ther (Heidelb). 2023 Aug;13(8):1831-1846. doi: 10.1007/s13555-023-00969-1. Epub 2023 Jul 11.
6
New-Onset Guttate Psoriasis: A Long-Term Follow-Up Study.新发点滴状银屑病:一项长期随访研究。
Dermatology. 2023;239(2):188-194. doi: 10.1159/000527737. Epub 2022 Dec 8.
7
Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriatic Arthritis.银屑病关节炎患者报告的病情缓解相关的人口统计学和临床因素
Dermatol Ther (Heidelb). 2022 Aug;12(8):1885-1895. doi: 10.1007/s13555-022-00770-6. Epub 2022 Jul 21.
8
Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriasis.与患者报告的银屑病缓解相关的人口统计学和临床因素
Dermatol Ther (Heidelb). 2022 Mar;12(3):753-760. doi: 10.1007/s13555-022-00692-3. Epub 2022 Mar 7.
9
Body surface area affected by psoriasis and the risk for psoriatic arthritis: a prospective population-based cohort study.银屑病受累体表面积与银屑病关节炎风险:一项前瞻性基于人群的队列研究。
Rheumatology (Oxford). 2022 May 5;61(5):1877-1884. doi: 10.1093/rheumatology/keab622.
10
A description of treatment patterns of psoriasis by medical providers and disease severity in US women.美国女性中医疗服务提供者对银屑病的治疗模式及疾病严重程度描述。
J Psoriasis Psoriatic Arthritis. 2021 Jan;6(1):45-51. doi: 10.1177/2475530320970531. Epub 2020 Nov 3.

本文引用的文献

1
Update on the epidemiology and systemic treatment of psoriasis.银屑病的流行病学及系统治疗进展
Expert Rev Clin Immunol. 2007 Mar;3(2):171-85. doi: 10.1586/1744666X.3.2.171.
2
The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004.美国成年人中既往诊断和未诊断的银屑病患病率:2003 - 2004年美国国家健康和营养检查调查结果
J Am Acad Dermatol. 2009 Feb;60(2):218-24. doi: 10.1016/j.jaad.2008.09.022. Epub 2008 Nov 20.
3
Determination of hand surface area as a percentage of body surface area by 3D anthropometry.通过三维人体测量法测定手部表面积占体表面积的百分比。
Burns. 2008 Dec;34(8):1183-9. doi: 10.1016/j.burns.2008.03.010. Epub 2008 Jun 9.
4
Psoriasis: cardiovascular risk factors and other disease comorbidities.银屑病:心血管危险因素及其他疾病合并症
J Drugs Dermatol. 2008 Apr;7(4):373-7.
5
Global assessment of psoriasis severity and change from photographs: a valid and consistent method.通过照片对银屑病严重程度进行整体评估及变化分析:一种有效且一致的方法。
J Invest Dermatol. 2008 Sep;128(9):2198-203. doi: 10.1038/jid.2008.68. Epub 2008 Apr 17.
6
The risk of mortality in patients with psoriasis: results from a population-based study.银屑病患者的死亡风险:一项基于人群的研究结果。
Arch Dermatol. 2007 Dec;143(12):1493-9. doi: 10.1001/archderm.143.12.1493.
7
Critical review of generic and dermatology-specific health-related quality of life instruments.对通用型及皮肤科专用的健康相关生活质量量表的批判性综述。
J Invest Dermatol. 2007 Dec;127(12):2726-39. doi: 10.1038/sj.jid.5701142. Epub 2007 Nov 8.
8
Measurement properties and interpretability of the Chronic respiratory disease questionnaire (CRQ).慢性呼吸系统疾病问卷(CRQ)的测量属性及可解释性
COPD. 2005 Mar;2(1):81-9. doi: 10.1081/copd-200050651.
9
Risk of myocardial infarction in patients with psoriasis.银屑病患者发生心肌梗死的风险
JAMA. 2006 Oct 11;296(14):1735-41. doi: 10.1001/jama.296.14.1735.
10
The risk of lymphoma in patients with psoriasis.银屑病患者患淋巴瘤的风险。
J Invest Dermatol. 2006 Oct;126(10):2194-201. doi: 10.1038/sj.jid.5700410. Epub 2006 Jun 1.

用于测量银屑病受累体表面积的患者报告银屑病严重程度(PREPI)的可靠性、有效性和对变化的反应性。

Reliability, validity and responsiveness to change of the Patient Report of Extent of Psoriasis Involvement (PREPI) for measuring body surface area affected by psoriasis.

机构信息

Department of Dermatology, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Br J Dermatol. 2010 Apr;162(4):835-42. doi: 10.1111/j.1365-2133.2009.09589.x. Epub 2009 Nov 10.

DOI:10.1111/j.1365-2133.2009.09589.x
PMID:19906216
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2877159/
Abstract

BACKGROUND

The development of a simple, reliable, valid and responsive method for measuring the extent of skin involvement in psoriasis is important for use in epidemiological studies.

OBJECTIVES

We sought to investigate the psychometric characteristics of the Patient Report of Extent of Psoriasis Involvement (PREPI), a single-question method for measuring body surface area affected by psoriasis.

METHODS

This was a cross-sectional study of 140 patients with psoriasis, with an exploratory prospective longitudinal cohort component. Reliability was measured via a test-retest approach and criterion validity was investigated by comparing the PREPI with an assessment of body surface area of involvement by a dermatologist. We additionally compared Skindex-29 scores with the PREPI. To demonstrate responsiveness and establish a minimally important difference in the PREPI, we created receiver operating characteristic curves for the PREPI instrument.

RESULTS

The test-retest reliability of the PREPI was nearly perfect [intraclass correlation coefficient (ICC) = 0.99, 95% confidence interval (CI) 0.97-0.99], and there was substantial agreement between patient and physician assessments (ICC = 0.82, 95% CI 0.75-0.87). The PREPI showed significant correlations with all Skindex-29 domains. We found the PREPI to be responsive to change and identified changes in the PREPI score that have good discrimination between patients with and without a minimally important clinical difference.

CONCLUSIONS

Our study suggests that the PREPI is a reliable, valid and responsive measure of body surface area affected by psoriasis that may be useful for future epidemiological research.

摘要

背景

开发一种简单、可靠、有效且敏感的方法来测量银屑病患者的皮肤受累程度对于在流行病学研究中使用非常重要。

目的

我们旨在研究患者报告的银屑病受累程度(PREPI)的心理测量学特征,该方法是一种测量银屑病受累体表面积的单问题方法。

方法

这是一项横断面研究,共纳入了 140 名银屑病患者,其中包括一个探索性前瞻性纵向队列部分。通过测试-重测方法来测量可靠性,通过比较 PREPI 与皮肤科医生评估的体表面积受累程度来评估标准效度。我们还比较了 Skindex-29 评分与 PREPI 的相关性。为了证明 PREPI 的反应性并确定 PREPI 中的最小临床差异,我们为 PREPI 仪器创建了接收者操作特征曲线。

结果

PREPI 的测试-重测可靠性几乎是完美的(组内相关系数 [ICC] = 0.99,95%置信区间 [CI] 0.97-0.99),患者和医生的评估之间存在高度一致性(ICC = 0.82,95% CI 0.75-0.87)。PREPI 与所有 Skindex-29 领域均存在显著相关性。我们发现 PREPI 对变化具有反应性,并确定了 PREPI 评分的变化可以很好地区分具有和不具有最小临床差异的患者。

结论

我们的研究表明,PREPI 是一种可靠、有效且敏感的测量银屑病患者体表面积受累程度的方法,可能对未来的流行病学研究有用。